Efficacy and safety of ipilimumab in combination with bevacizumab as first-line treatment in advanced cutaneous and acral melanoma: a prospective, single-arm clinical study (ChiCTR) - Oct 16, 2026 - P=N/A | N=34 | Recruiting | Sponsor: Anyang Tumour Hospital; Anyang Tumour Hospital
New trial • Gastric Cancer • Gastroesophageal Junction Adenocarcinoma • Melanoma • Oncology • Solid Tumor • HER-2
|